ADAG - Adagene to Present at Investor and Scientific Conferences in September | Benzinga
– Adagene's CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies –
SAN DIEGO and SUZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the company's participation in several upcoming investor and scientific conferences.
Adagene's management will review recent clinical data demonstrating the best-in-class safety and efficacy profile for its masked anti-CTLA-4 candidate, ADG126. Details include:
Morgan Stanley 21st Annual Global Healthcare Conference
- Date: Monday, September 11, 2023
- Fireside Chat Time: 4:15 PM-4:45 PM ...